RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	44.54	40.44	114.05	95.87	70.83
Cash & Short-Term Investments	44.54	40.44	114.05	95.87	70.83
Cash Growth	10.13%	-64.54%	18.97%	35.34%	103.88%
Accounts Receivable	0.95	-	0.25	43.91	56.42
Other Receivables	2.08	2.13	2.9	-	-
Receivables	3.03	2.13	3.15	43.91	56.42
Inventory	0.78	0.84	1.83	21.31	24.38
Prepaid Expenses	8.62	12.9	12.59	11.55	20.72
Other Current Assets	-	3.06	41.53	-	-
Total Current Assets	56.98	59.38	173.15	172.63	172.36
Property, Plant & Equipment	1.79	2.23	4.34	35.22	31.26
Goodwill	55.85	55.85	55.85	100.86	100.86
Other Intangible Assets	13.9	27.21	35.09	153.99	490.39
Other Long-Term Assets	-	-	102.51	0.56	0.75
Total Assets	128.51	144.67	370.95	463.26	795.62
Accounts Payable	2.41	3.78	3.13	8.5	24.87
Accrued Expenses	13.47	13.01	16.86	31.02	37.95
Current Portion of Long-Term Debt	1.43	2.41	-	-	1.77
Current Portion of Leases	0.45	0.84	1.22	2.19	0.12
Current Income Taxes Payable	0.04	0	0	-	-
Current Unearned Revenue	1.92	0.07	-	-	0.1
Other Current Liabilities	-	-	34.58	34.23	49.18
Total Current Liabilities	19.72	20.11	55.78	75.94	114
Long-Term Debt	55.5	43.8	219.53	267.95	266.8
Long-Term Leases	0.11	0.59	0.87	3.16	0.14
Long-Term Deferred Tax Liabilities	0.06	0.15	0.35	1.5	28.29
Other Long-Term Liabilities	2.02	3.29	0.57	-	2.54
Total Liabilities	77.42	67.94	277.09	348.55	411.78
Common Stock	0.99	0.83	0.63	0.52	0.53
Additional Paid-In Capital	619.32	591.73	548.07	489.44	487.29
Retained Earnings	-569.22	-517.53	-452.61	-373.02	-102.12
Comprehensive Income & Other	-	1.7	-2.23	-2.23	-1.85
Shareholders' Equity	51.09	76.73	93.86	114.71	383.85
Total Liabilities & Equity	128.51	144.67	370.95	463.26	795.62
Total Debt	57.49	47.65	221.62	273.3	268.83
Net Cash (Debt)	-12.95	-7.2	-107.56	-177.43	-198
Net Cash Per Share	-0.14	-0.11	-1.77	-3.39	-4.37
Filing Date Shares Outstanding	99.35	83.52	62.72	58.9	52.52
Total Common Shares Outstanding	99.16	83.3	62.55	51.85	52.52
Working Capital	37.25	39.27	117.37	96.69	58.36
Book Value Per Share	0.52	0.92	1.50	2.21	7.31
Tangible Book Value	-18.65	-6.32	2.92	-140.13	-207.4
Tangible Book Value Per Share	-0.19	-0.08	0.05	-2.70	-3.95
Land	-	-	-	2.12	2.12
Buildings	-	-	-	11.64	11.57
Machinery	1.34	1.31	2.28	25.93	22.28
Construction In Progress	0.7	0.07	0.03	1.41	3.42
Leasehold Improvements	0.39	1.13	2.21	3.42	2.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.